Wegovy

IBD
Biotech

Vanda tackles Wegovy-driven vomiting, sparking race to ph. 3

With the trial linking tradipitant to reduced nausea and vomiting in Wegovy patients, the biotech is gearing up for a phase 3 trial in the setting.
Nick Paul Taylor Nov 18, 2025 10:44am
ChatGPT said Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin
Favicon Fierce Pharma

Big Pharma bets big on MASH with a new combo playbook

Oct 17, 2025 9:30am
obesity overweight weight loss weigh

Novo pushes ahead with amylin after seeing ph. 3 tolerability

Sep 16, 2025 8:12am
Doustdar
Favicon Fierce Pharma

Novo charts major restructuring, layoffs under new CEO

Sep 10, 2025 8:41am
Doustdar
Favicon Fierce Pharma

Novo Nordisk names new CEO as it cuts sales, profit outlook

Jul 29, 2025 10:10am
Ozempic syringe pen and measuring tape on blue background

Novo plots ph. 3 trials for next-gen obesity asset amycretin

Jun 13, 2025 10:35am